Synergistic induction of the Fas (CD95) ligand promoter by Max and NFκB in human non-small lung cancer cells
- 2 July 2004
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 299 (1) , 227-235
- https://doi.org/10.1016/j.yexcr.2004.05.031
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic ProgressionCell, 2002
- Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomasThe Journal of Pathology, 2002
- Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapyCell Death & Differentiation, 2001
- The Max Network Gone MadMolecular and Cellular Biology, 2001
- Phorbol Ester-induced Expression of Airway Squamous Cell Differentiation Marker, SPRR1B, Is Regulated by Protein Kinase Cδ/Ras/MEKK1/MKK1-dependent/AP-1 Signal Transduction PathwayJournal of Biological Chemistry, 2000
- Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma CellsJournal of Biological Chemistry, 2000
- Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expressionOncogene, 1998
- Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cellsOncogene, 1997
- Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomasNature, 1995
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992